Endemic Knowledge- Sickle Cell Disease

Due to global migration, the prevalence of sickle cell disease in Canada is increasing. People of African, Arab, and Indian backgrounds in Canada are the most affected and can benefit from ITP expertise in treating this condition in high-prevalence countries. Canada has a strong presence of ITPs from the high prevalence source countries for Sickle Cell Disease.

Disease: Sickle Cell Disease (DONE)
Prevalence in Canada:
Due to global migration, the prevalence of sickle cell disease is increasing among people of African, Arab, and Indian backgrounds in Canada. Approximately 3,500 people in Ontario and 6,500 people across Canada are affected.
Prevalence in Source Countries:
Most sickle cell disease cases occur in Nigeria, the Democratic Republic of the Congo, and India. In these regions, the disease affects up to 2% of the population, with India having over 20 million patients.
Commentary:
ITPs can significantly improve the management of sickle cell disease in Canada. Their expertise in treating this condition in high-prevalence countries can enhance early diagnosis and care. They can also address cultural and linguistic barriers, ensuring better patient compliance and outcomes. This is particularly important as the disease is more common among immigrants from regions with high prevalence.